Cargando…
CD98hc is a target for brain delivery of biotherapeutics
Brain exposure of systemically administered biotherapeutics is highly restricted by the blood-brain barrier (BBB). Here, we report the engineering and characterization of a BBB transport vehicle targeting the CD98 heavy chain (CD98hc or SLC3A2) of heterodimeric amino acid transporters (TV(CD98hc))....
Ejemplares similares
-
Author Correction: CD98hc is a target for brain delivery of biotherapeutics
por: Chew, Kylie S., et al.
Publicado: (2023) -
A TREM2-activating antibody with a blood–brain barrier transport vehicle enhances microglial metabolism in Alzheimer’s disease models
por: van Lengerich, Bettina, et al.
Publicado: (2023) -
Tumor immunologic heterogeneity influences response to radiation and combination immunotherapy
por: Aguilera, Todd, et al.
Publicado: (2015) -
Multidimensional Proteome Profiling of Blood-Brain Barrier Perturbation by Group B Streptococcus
por: Campeau, Anaamika, et al.
Publicado: (2020) -
Molecular architecture determines brain delivery of a transferrin receptor–targeted lysosomal enzyme
por: Arguello, Annie, et al.
Publicado: (2022)